(Q36303938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Recent developments in therapeutic cancer vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Michael A Morse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stephen Chui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Amy Hobeika

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Timothy Clay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

108-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

Toward a definition of self: proteomic evaluation of the class I peptide repertoire

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic m

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Cancer vaccines: pessimism in check

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Cancer vaccines: pessimism in check

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

The first 1000 dendritic cell vaccinees.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Current developments in cancer vaccines and cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Part II: Vaccines for haematological malignant disorders.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Part I: Vaccines for solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Extramedullary sites of involvement in hematologic malignancies: case 1. Multifocal intracranial involvement with mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

A listing of human tumor antigens recognized by T cells: March 2004 update

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

An antigenic peptide produced by peptide splicing in the proteasome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

An epigenetically altered tumor cell vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0098

7 January 2021

Identifiers

DOI

10.1038/NCPONC0098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16264883%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference